Federal Register #2026-18008

Emergency Use Authorization Declaration for Military Medical Needs

This notice from the Department of Health and Human Services (HHS) announces an emergency use authorization declaration for military medical needs: - Government Buyer: - Department of Health and Human Services (HHS) - Purpose: - Declaration enables emergency use of drugs for U.S. military forces facing chemical, biological, radiological, nuclear, or combat-related threats - Focus is on addressing unmet medical needs, specifically moderate to severe acute pain in casualties - OEMs and Vendors: - No specific OEMs, vendors, or manufacturers are named in the notice - Products/Services Requested: - No specific drugs, part numbers, or quantities are listed - Authorization covers drugs identified and supported by the Department of War for emergency use - Unique/Notable Requirements: - Emergency use is limited to drugs for military operations-related medical needs - Any future emergency use authorizations (EUAs) will be announced in the Federal Register - Declaration is pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act - No procurement or contract opportunity is currently announced; this is a regulatory declaration

Description

The Department of Health and Human Services (HHS) issued a notice declaring an emergency use authorization pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act. This declaration follows a determination by the Secretary of War of a military emergency involving a heightened risk to U.S. military forces from chemical, biological, radiological, or nuclear agents or military combat agents. The authorization allows for the emergency use of drugs to manage moderate to severe acute pain in casualties related to these threats. The declaration is effective as of August 31, 2026, based on the determination made on July 15, 2026.

View original listing